Vaccination

More COVID-19 vaccines in the pipeline as US effort ramps up

A huge U.S. study of another COVID-19 vaccine candidate got underway Monday as states continue to roll out scarce supplies of the first shots to a nation anxiously awaiting relief from the catastrophic outbreak.

Vaccination

Phase 3 trials begin for Novavax vaccine in US, Mexico

Clinical trials to determine the safety and efficacy of a COVID-19 vaccine candidate from American biotech company Novavax have begun in the United States and Mexico, the US National Institutes of Health (NIH) announced Monday.

Medical research

Phase 3 trial of Novavax investigational COVID-19 vaccine opens

The Phase 3 trial of another investigational coronavirus disease 2019 (COVID-19) vaccine has begun enrolling adult volunteers. The randomized, placebo-controlled trial will enroll approximately 30,000 people at approximately ...

Diseases, Conditions, Syndromes

India's virus cases cross 10 million as new infections dip

India's confirmed coronavirus cases have crossed 10 million with new infections dipping to their lowest levels in three months, as the country prepares for a massive COVID-19 vaccination in the new year.

Vaccination

Behind in vaccine race, CureVac bets on 'easier' jab

CureVac CEO Franz-Werner Haas readily admits his German biotech firm is "a bit behind" in the COVID-19 vaccine race, despite using the same cutting-edge technology as rivals Moderna and Pfizer/BioNTech.

Vaccination

Cigarette maker BAT announces US vaccine trial launch

British cigarette maker BAT said Wednesday that its US biotech division Kentucky BioProcessing will launch trials of a potential coronavirus vaccine, developed using tobacco plant technology.

page 2 from 33